Abstracts

PREVALENCE AND PROGNOSTIC IMPACT OF PULMONARY HYPERTENSION IN HIV-INFECTED ADULTS

HIV- infected individuals are at increased risk for the development of pulmonary hypertension (PH). The prevalence of PH, risk factors associated with its development, and the prognostic impact in HIV infected individuals are poorly understood. We used Vanderbilt’s de-identified electronic medical record (the Synthetic Derivative) to identify HIV infected individuals defined using International Classification of…

SAME SAME BUT DIFFERENT? RISK OF DAA THERAPY FAILURE IN REAL-LIFE HCV/HIV COINFECTION

Directly-acting agents (DAA) against HCV have impressively improved treatment of chronic hepatitis C coinfection. However, relapses still occur. Therefore we assessed the influence of traditional risk factors on treatment outcome in HCV/HIV coinfected patients in the German hepatitis C cohort (GECCO). The GECCO cohort is a multicenter cohort from 9 sites in Germany. All HCV/HIV…

DIRECT-ACTING ANTIVIRALS IMPROVE ACCESS TO CARE AND CURE FOR PATIENTS WITH HIV-HCV

Prior to the approval of direct-acting antivirals (DAA), uptake of curative hepatitis C virus (HCV) treatment was low, particularly for HIV/HCV co-infected patients. DAA offers >95% sustained virologic response (SVR) for the vast majority of HCV-infected patients, regardless of HIV-1 infection. Although safety and efficacy of HCV therapies have improved, challenges have emerged including high…

HIV AS A RISK FACTOR OF AIRWAY OBSTRUCTIVE DISEASE

We previously showed high prevalence of chronic obstructive pulmonary disease (COPD) in an all-smoking cohort of HIV-individuals. Whether COPD prevalence is higher in HIV-individuals than in the general population remains to be determined. The objective of this study was to compare the prevalence of airflow obstruction (AO) in HIV-individuals and in age and gender matched…